These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2552925)

  • 1. Interaction of amiodarone and its analogs with calmodulin.
    Deziel MR; Davis PJ; Davis FB; Cody V; Galindo J; Blas SD
    Arch Biochem Biophys; 1989 Nov; 274(2):463-70. PubMed ID: 2552925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of calmodulin properties by amiodarone and its major metabolite desethylamiodarone.
    Vig PJ; Yallapragada PR; Kodavanti PR; Desaiah D
    Pharmacol Toxicol; 1991 Jan; 68(1):26-33. PubMed ID: 1848930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid inhibits calmodulin binding to human erythrocyte membranes and reduces membrane Ca2(+)-adenosine triphosphatase activity.
    Davis FB; Smith TJ; Deziel MR; Davis PJ; Blas SD
    J Clin Invest; 1990 Jun; 85(6):1999-2003. PubMed ID: 2161434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calmodulin-drug interaction. A fluorescence and flow dialysis study.
    Buerkler J; Krebs J; Carafoli E
    Cell Calcium; 1987 Apr; 8(2):123-43. PubMed ID: 3036362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone is a potent calmodulin antagonist.
    Nokin P; Blondiaux JP; Schaeffer P; Jungbluth L; Lugnier C
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):367-73. PubMed ID: 2544810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors.
    Gietzen K; Sadorf I; Bader H
    Biochem J; 1982 Dec; 207(3):541-8. PubMed ID: 6299272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.
    Silver PJ; Connell MJ; Dillon KM; Cumiskey WR; Volberg WA; Ezrin AM
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):675-82. PubMed ID: 2488107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-induced exposure of a hydrophobic surface on calmodulin.
    LaPorte DC; Wierman BM; Storm DR
    Biochemistry; 1980 Aug; 19(16):3814-9. PubMed ID: 6250577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine transport regulation by calcium and calmodulin: role of Ca(2+)-ATPase.
    Khan NA; Sezan A; Quemener V; Moulinoux JP
    J Cell Physiol; 1993 Dec; 157(3):493-501. PubMed ID: 8253860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two types of calmodulin antagonists: a structurally related interaction.
    Inagaki M; Hidaka H
    Pharmacology; 1984; 29(2):75-84. PubMed ID: 6089236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin antagonists' binding sites on calmodulin.
    Tanaka T; Ohmura T; Hidaka H
    Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence studies on calmodulin binding to erythrocyte Ca2(+)-ATPase in different oligomerization states.
    Kosk-Kosicka D; Bzdega T; Johnson JD
    Biochemistry; 1990 Feb; 29(7):1875-9. PubMed ID: 2139581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
    Williams JP; McDonald JM; McKenna MA; Jordan SE; Radding W; Blair HC
    J Cell Biochem; 1997 Sep; 66(3):358-69. PubMed ID: 9257192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin antagonistic action of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4- ([4-(2-methoxyphenyl)-1-piperazinyl]methyl)isoquinoline.
    Nakajima T; Okada T; Kuruma I; Yoshizaki H; Satoh T; Kuwahara T; Nakamura K
    Arzneimittelforschung; 1987 Jun; 37(6):674-9. PubMed ID: 2822056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative calcium binding and calmodulin regulation in the calcium-dependent adenosine triphosphatase purified from the erythrocyte membrane.
    Kosk-Kosicka D; Inesi G
    FEBS Lett; 1985 Sep; 189(1):67-71. PubMed ID: 3161753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte Ca2(+)-ATPase: activation by enzyme oligomerization versus by calmodulin.
    Kosk-Kosicka D; Bzdega T; Wawrzynow A; Scaillet S; Nemcek K; Johnson JD
    Adv Exp Med Biol; 1990; 269():169-74. PubMed ID: 2141217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin antagonistic action of new 1,5-benzothiazepines derived from diltiazem.
    Suzuki T; Ohashi M; Takaiti O; Harigaya S
    Arzneimittelforschung; 1994 Jan; 44(1):3-6. PubMed ID: 8135875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminalplasmin. An endogenous calmodulin antagonist.
    Gietzen K; Galla HJ
    Biochem J; 1985 Aug; 230(1):277-80. PubMed ID: 2996494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acylphosphatase on human erythrocyte membrane Ca2(+)-ATPase.
    Nassi P; Nediani C; Liguri G; Taddei N; Ruggiero M; Ramponi G
    Biochem Biophys Res Commun; 1990 Apr; 168(2):651-8. PubMed ID: 2159297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.